专家述评

肝胆胰外科中吲哚菁绿荧光成像技术的应用研究进展

Progress of indocyanine green fluorescence imaging in hepatobiliary and pancreatic surgery

:133-143
 
        吲哚菁绿(ICG)荧光成像技术基于ICG独特的代谢特性及近红外光激发特性, 通过动态荧光显影成像为手术提供精准导航, 其在肝胆胰外科领域展现出重要的应用价值。随着多版国内外指南的迭代更新, ICG荧光导航技术已被确立为肝胆胰外科手术的重要辅助手段, 其安全性和有效性得到充分验证。文章就ICG荧光成像技术的原理、在肝胆胰外科应用中的现状、在临床应用中面临的问题以及其应用展望展开综述。
       Based on the unique metabolic properties and near-infrared light excitation characteristics of indocyanine green(ICG), the ICG fluorescence imaging technology provides dynamic fluorescence imaging for precise surgical navigation.This technology has demonstrated significant value in hepatobiliary and pancreatic surgery.With iterative updates to international and domestic guidelines, ICG-based fluorescence navigation has been established as an essential adjunctive tool in hepatopancreaticobiliary procedures, with its safety and efficacy validated through extensive clinical research.This review systematically explores the underlying principles of ICG fluorescence imaging, its current applications in liver, biliary, and pancreatic surgeries, the challenges encountered in clinical practice, and future directions for technological optimization and clinical translation
专家述评

非编码 RNA 在泛血管疾病中的研究进展

Research progress of non-coding RNAs in panvascular diseases

:122-132
 
       泛血管疾病(PVD)是一类以动脉粥样硬化为共同病理基础、累及心、脑、肾及外周血管系统的临床综合征, 具有多血管床共病特征, 发病率高、致残致死率大。非编码RNA(ncRNA)作为基因表达的重要调控因子, 在PVD的发生发展中发挥关键作用。微小RNA(miRNA)、长链非编码RNA(lncRNA)、环状RNA(circRNA)等ncRNA通过调节炎症反应、内皮功能、血管重塑、代谢稳态等多路径参与PVD的病理过程, 并展现出时空特异性和双向调控特征。最新研究揭示ncRNA在临床中的诊断预测及靶向干预潜力, 包括外泌体载体及circRNA递送系统等新策略。此外, 中医药通过调控ncRNA网络, 干预血瘀、痰浊等证型相关通路, 体现中西医结合治疗的系统优势。本文系统综述了ncRNA在PVD中的作用机制与研究进展, 强调其在精准诊疗与转化研究中的应用前景, 并指出未来需加强基础与临床协同、推进个体化干预策略的落地实施。
       Panvascular diseases(PVD)are a group of clinical syndromes characterized by atherosclerosis as a common pathological foundation, involving heart,brain,kidneys,and peripheral vascular systems.These diseases often exhibit multi-vascular bed comorbidities and are associated with high incidence,disability, and mortality rates.Non-coding RNAs(ncRNAs), as key regulators of gene expression, play a crucial role in the onset and progression of PVD.Various types of ncRNAs—including microRNAs(miRNAs), long non-coding RNAs(lncRNAs), and circular RNAs(circRNAs)—are involved in the pathological processes of PVD through multiple pathways, such as modulation of inflammatory responses, endothelial function, vascular remodeling, and metabolic homeostasis, exhibiting spatiotemporal specificity and bidirectional regulatory effects.Recent studies have highlighted the potential of ncRNAs in clinical diagnosis, prognosis, and targeted therapy,with novel strategies including exosome-based delivery and circRNA-targeting systems.In addition, traditional Chinese medicine(TCM)exerts regulatory effects on ncRNA networks to intervene in syndrome-specific pathways, such as those related to blood stasis and phlegm-dampness, reflecting the systemic advantages of integrating TCM with Western medicine.This review systematically summarizes the regulatory mechanisms and research progress of ncRNAs in PVD,emphasizes their potential in precision medicine and translational research, and proposes the need to strengthen collaboration between basic and clinical studies to facilitate the implementation of personalized therapeutic strategies.
综述

青少年群体述情障碍的研究进展

Advances in the study of alexithymia among adolescent populations

:30-38
 
       述情障碍(alexithymia)是一种主要表现为难以识别和描述情绪情感、社交依附和人际交往能力匮乏的人格特质与心理特征。近年来,述情障碍的发生在青少年群体中日益普遍,这不仅对青少年的身心健康造成威胁,还给家庭与社会带来沉重负担。因此,本研究通过系统回顾国内外相关文献,综述青少年述情障碍的评估工具、影响因素及干预方式,旨在为青少年述情障碍的早期识别与预防,以及干预措施的制定与应用提供参考依据。
    Alexithymia is a psychological trait characterized by difficulty in identifying and describing emotional feelings,as well as deficits in social attachment and interpersonal communication skills.In recent years,the prevalence of alexithymia among adolescents has become increasingly common,posing significant threats to their physical and mental health and imposing a heavy burden on families and society.This study conducts a systematic review of relevant literature from domestic and international databases to examine the influencing factors,assessment tools,and intervention strategies for adolescent alexithymia.The findings aim to provide a reference for early identification,prevention,and the development and application of targeted interventions for adolescent 
alexithymia.
综述

中医药调控 CD4+ T 细胞亚群防治动脉粥样硬化的研究进展

Research progress on the regulation of CD4+ T cell subsets by traditional Chinese medicine for the prevention and treatment of atherosclerosis

:24-29
 
       动脉粥样硬化(AS)是一种起始于炎症介导的内皮损伤的慢性血管疾病,其本质是免疫炎症驱动的病理过程,是众多心血管疾病的病理基础。CD4+  T细胞亚群[包括辅助性T细胞1型(T helper 1 cell,Th1)、Th2、Th17、调节性T细胞等]通过分泌特异性细胞因子参与AS的炎症反应,其中促炎性CD4+  T细胞与抗炎性CD4+  T细胞的抗炎功能失衡是推动斑块进展的关键环节,在AS斑块形成与发展中起关键作用。近年来,多项研究表明某些中药单体、经典复方及其有效成分,具有多靶点、多层次机制调控CD4+  T细胞分化及功能,这些作用共同减轻血管内皮炎症反应、抑制巨噬细胞泡沫化及平滑肌细胞迁移等,延缓AS斑块形成与发展,为AS防治提供了新思路,展现了中医药在该领域的研究展现出独特优势与广阔前景,本文综述了中医药通过干预CD4+  T细胞亚群平衡防治AS的最新研究进展,及其影响相关细胞因子网络及关键信号通路的作用机制,为开发具有多靶点协同优势的创新中药与中西医结合治疗方案提供了关键理论依据与实践方向。
       Atherosclerosis(AS)is a chronic vascular disease that originates from inflammation mediated endothelial 
damage.Its essence is a pathological process driven by immune inflammation,and it is the pathological basis of many cardiovascular diseases.CD4+  T cell subsets(including Th1,Th2,Th17,Treg,etc.)participate in the inflammatory response of AS by secreting specific cytokines.The imbalance of anti-inflammatory function between pro-inflammatory CD4+  T cells and anti-inflammatory CD4+T cells is a key link in promoting plaque progression and playing a crucial role in the formation and development of AS plaques.In recent years,a number of studies have shown that the monomers,classic prescriptions and their effective ingredients of Chinese herbs have the effect of multi-target,multi-level mechanism to regulate the differentiation and function of CD4+  T cells.These effects together reduce the inflammatory reaction of vascular endothelium,inhibit the foam formation of macrophages and smooth muscle cell migration,delay the formation and development of AS plaque,provide new ideas for the prevention and treatment of AS,and make the research of Chinese medicine show unique advantages and broad prospects in this field.This article  reviews the latest  research progress of Chinese medicine in the prevention and treatment of AS by intervening in the balance of CD4+  T cell subsets,as well as the mechanism of its effects on related cytokine networks and key signal pathways.This provides a key theoretical basis and practical direction for the development of innovative traditional Chinese medicine and integrated traditional Chinese and Western medicine treatment plans with multi-target synergistic advantages.
综述

缺氧诱导因子调控的铁死亡及其在胃肠道疾病中的作用研究进展

Research progress in hypoxia-inducible factor regulated ferroptosis and its implications in gastrointestinal disease

:16-23
 
       铁死亡是一种以铁依赖性脂质过氧化为特征的程序性细胞死亡形式。近年来研究表明,铁死亡与缺氧应答的关键调控因子——缺氧诱导因子(HIF)存在密切关联。HIF(包括HIF-1α、HIF-2α、HIF-3α三种亚型)调控的铁死亡在结直肠癌、胃癌、溃疡性结肠炎及其他胃肠黏膜损伤性疾病中发挥作用,影响疾病的发生发展。但目前关于HIF-铁死亡通路在不同胃肠道疾病中的差异化作用及调控机制尚未完全阐明。因此,本文对HIF各亚型调控铁死亡的分子机制及其在胃肠道疾病中的作用进行综述,以期为靶向HIF-铁死亡通路治疗相关疾病提供新的思路。
       Ferroptosis is a form of regulated cell death characterized by iron-dependent lipid peroxidation.Recent 
studies have demonstrated a close association between ferroptosis and hypoxia-inducible factor(HIF),the key  regulator of the hypoxic response.Ferroptosis regulated by HIF(comprising three isoforms:HIF-1α,HIF-2α,and HIF-3α)plays a  role in colorectal cancer,gastric cancer,ulcerative colitis,and other gastrointestinal mucosal injury diseases,impacting their initiation and progression.However,the differential roles and regulatory mechanisms of the HIF-ferroptosis pathway in various gastrointestinal diseases remain incompletely elucidated.Therefore,this  review  summarizes the molecular mechanism networks through which individual HIF isoforms regulate ferroptosis and their roles in gastrointestinal diseases,with the aim of providing new perspectives for targeting the HIF-ferroptosis pathway to treat relevant diseases.
专家述评

青少年非自杀性自伤行为研究进展

Advances in the study of non-suicidal self-injury in adolescents

:1473-1481
 
       非自杀性自伤行为(NSSI)是指个体在没有自杀意图的情况下,故意对自己身体进行伤害的行为。近年来,NSSI在全球范围内整体呈上升趋势,尤其在青少年群体中日益普遍,这与青少年的年龄特点、心理及生物学特征、社会压力等因素密切相关。有研究表明,NSSI是自杀行为的独立危险因素,不仅对青少年健康造成严重影响,也给家庭和社会带来了沉重的负担。因此,本文通过系统回顾NSSI相关文献,阐述其流行病学现况、影响因素和干预措施,旨在为早期识别高危人群、预防青少年NSSI行为的发生以及制定相应的干预策略提供科学依据。
       Non-suicidal self-injury(NSSI)is the behavior in which an individual intentionally inflicts harm on his or her own body without suicidal intent.In recent years,NSSI has been on the rise globally,especially among adolescents,which is closely related to the age characteristics,psychological and biological characteristics,and social pressure.Some studies have shown that NSSI is an independent risk factor for suicidal behavior,which not only poses a serious impact on the health of adolescents,but also imposes a heavy burden on families and society.Therefore,this article systematically reviews relevant literatures on NSSI,mainly elaborating the epidemiological status,influencing factors and interventions.We aim to provide a scientific basis for the early identification of high-risk populations,the prevention of NSSI in adolescents and the development of corresponding intervention strategies
综述

自发性脑出血监测方法的研究进展

Progress in monitoring spontaneous cerebral hemorrhages

:1330-1337
 
自发性脑出血由于外伤性原因引起脑实质出血作为神经系统急危重症,该患病率约占所有脑卒中的10%~15%, 具有高患病率、高死亡率、高致残率的特点, 随着年龄的不断增长血管逐渐变薄、失去弹性,受到外在原因干扰时, 导致出血, 形成血肿, 依据血肿的不同程度, 患者的生存及预后有着显著的差异。因此快速且及时识别自发性脑出血尤为重要,可为临床医生评估患者病情变化及预后具有重要指导的意义, 然而在临床实践过程中对于快速识别脑出血的方法有所欠缺, 需要进一步优化其监测方法。因此本文综述了自发性脑出血的监测方法, 探讨通过无创监测、有创监测及联合监测自发性脑出血为临床快速高效判断脑出血提供科学的依据和参考。
The incidence of spontaneous cerebral hemorrhage accounts for about 10% to 15% of the stroke cases, and it has the characteristics of high incidence, high mortality rate, and high disability rate.It is very important to quickly identify spontaneous cerebral hemorrhage, which has important guiding significance for clinical doctors to evaluate patient condition changes and prognosis.This article reviews the latest research on non-invasive monitoring, invasive monitoring, and combined monitoring of spontaneous cerebral hemorrhage.
专家述评

智能可变形纳米载体的设计策略及其抗肿瘤应用研究进展

Recent development of smart deformable nanocarriers for antitumor application

:1311-1329
 
近年来, 药物递送系统在肿瘤靶向治疗领域取得了显著进展, 已有多种递药系统获批临床应用。其中, 纳米药物因其能够减少传统小分子化疗药物的毒副作用、提高药物生物利用度,并通过增强通透性与滞留效应(EPR效应)实现肿瘤的被动靶向, 从而显著提升治疗效果, 受到广泛关注。尤其是具备尺寸可调、肿瘤特异性聚集、刺激响应性崩解及形貌转变等多功能的智能可变形纳米载体, 已成为当前纳米递药载体研究的热点。这类载体能够感应肿瘤微环境中的特定刺激信号(如酸性pH值、过氧化还原状态、酶活性或过表达细胞因子), 实现包括尺寸调控、聚集组装、结构崩解与形态重构等在内的多种动态变形行为, 从而提升药物在肿瘤部位的滞留时间、渗透深度及控释能力, 最终获得更优的抗肿瘤疗效。例如在肿瘤组织中实现纳米载体尺寸缩小可增强药物的组织穿透力; 纳米粒子聚集变大会延长药物在病灶处的滞留时间; 而快速响应性崩解则有助于药物在肿瘤局部实现高效释放。这些智能变形策略为纳米药物递送系统提供了更高的治疗可控性与精准性。基于其多样化的响应特性和结构可塑性, 智能变形纳米载体在推动抗肿瘤药物的个体化治疗及联合疗法应用方面展现出巨大潜力。本文综述了近年来基于智能变形纳米载体增强抗肿瘤效果的研究进展,系统梳理了其设计策略, 并深入探讨了其在肿瘤精准治疗中的应用前景。
In recent years, drug delivery systems have made remarkable progress in the field of tumor-targeted therapy, with several platforms already approved for clinical use.Among them, nanomedicines have attracted considerable attention due to their ability to mitigate the side effects of conventional small-molecule chemotherapeutics, improve bioavailability, and passively accumulate at tumor sites via the enhanced permeability and retention(EPR)effect, thereby enhancing therapeutic efficacy.Of particular interest are stimuli-responsive, shape-transformable nanocarriers, which exhibit unique properties such as tunable size, tumor-specific accumulation, and structural adaptability in response to tumor-associated cues.These intelligent deformable nanocarriers are capable of undergoing various dynamic transformations—including aggregation, disassembly, size modulation, and morphological transitions—triggered by specific stimuli in the tumor microenvironment(TME), such as pH, redox potential,enzymes,or cytokines.Such transformations enhance drug retention at tumor sites, improve intratumoral penetration, and enable spatiotemporally controlled drug release, ultimately resulting in superior antitumor efficacy.For instance, nanosystems that shrink in size at tumor sites can promote deeper tissue penetration, while those that aggregate into larger assemblies can prolong local drug retention.Conversely, carriers that disassemble rapidly under tumor-specific stimuli allow for burst release of the encapsulated payload precisely at the disease site.These adaptive features hold great promise for improving the therapeutic performance of nanomedicines. Furthermore, the multifunctionality of intelligent deformable nanocarriers supports the development of personalized treatment regimens and combination therapies, offering novel strategies for cancer management.This review highlights recent advances in the design and application of shape-transformable nanocarriers for enhanced anticancer drug delivery, summarizing design principles and exploring their emerging potential in precision oncology.
综述

大蒜对糖脂代谢调节作用的研究进展

Garlic and its regulatory effects on glucose and lipid metabolism

:472-477
 
大蒜为百合科葱属植物的地下鳞茎,具有药食两用的价值,其含有大蒜素、二烯丙基硫醚、二烯丙基二硫醚、二烯丙基三硫醚、 硫-烯丙基半胱氨酸等多种生物活性成分,具有抗氧化、抗感染、免疫调节、心血管保护、抗癌等作用。不仅如此,大蒜在糖脂代谢的调节中功效显著,且相关机制日益明晰,主要包括保护胰岛β细胞功能、改善胰岛素抵抗、阻止脂肪细胞生长、抑制脂合成代谢及调节肠道菌群分布等。不同的提取工艺可影响大蒜的功效,其提取手段及药效关系值得进一步研究。
Garlic has values of both medicine and food,with rich allicin,diallyl disulfide(DADS),diallyl trisulfide(DATS)and other garlic sulfur contents,which have been found to have multiple effets such as antioxidant,anti-infection,immunomodulatory,cardiovascular protection,anti-cancer,etc.Moreover,numerous studies have demonstrated that garlic plays an important role in the regulation of glycose and lipid metabolism,and the relevant mechanisms are becoming better understood,including protecting pancreatic β cells,improving insulin resistance,preventing the growth of fat cells,inhibiting lipid anabolism and adjusting the distribution of intestinal microflora.Different extraction processes can affect the efficacy of garlic,and further investigations are needed to elucidate the relationship between effective extraction methods and pharmacodynamic properties.
综述

减重手术对炎症因子影响的研究进展

Research progress on the impact of bariatric surgery on inflammatory factors

:463-471
 
肥胖是一种以慢性低度炎症为特征的进展性疾病,与多种代谢性疾病的发生、发展密切相关。脂肪组织作为一种内分泌和免疫器官,可分泌多种生物活性物质及炎症因子,参与肥胖患者体内的代谢过程。减重手术是治疗病态性肥胖及相关代谢性疾病的有效方法之一,能够调节机体内的炎症反应、有效改善代谢状态。但减重手术对于炎症因子的作用如何,目前国内外的文献证据仍有争议。本文将系统阐述肥胖与代谢性炎症的关系以及减重手术对炎症因子的影响,旨在为肥胖代谢外科的诊疗过程提供参考。
Obesity is a progressive disease characterized by chronic low-grade inflammation,which is closely related to the occurrence and development of a variety of metabolic diseases.As an endocrine and immune organ,adipose tissue can secrete a variety of bioactive substances and inflammatory factors,which participate in the metabolic process of obese patients.Bariatric surgery is one of the effective methods for the treatment of morbid obesity and related metabolic diseases,which can regulate the inflammatory response in the machine and effectively improve the metabolic state.However,the effect of bariatric surgery on inflammatory factors is still controversial at home and abroad.This article will systematically explain the relationship between obesity and metabolic inflammation and the effect of bariatric surgery on inflammatory factors,aiming to provide a reference for the diagnosis and treatment process of bariatric surgery.
出版者信息








《广州医药》公众号